Paragon Gene Therapy, a unit of Catalent Biologics

57 articles with Paragon Gene Therapy, a unit of Catalent Biologics

• Paragon Bioservices Announces Two Key Leadership Promotions

  8/8/2018

  Paragon Bioservices announces two key leadership promotions.

• Catalyst Pharmaceuticals Expands Commercial Leadership Team

  8/6/2018

  Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of several key members to its commercial leadership team.

• Paragon Bioservices Fills Key Leadership Position with New CFO Hire

  6/6/2018

  Seasoned Executive Gerard Fleury Joins the Company as Chief Financial Officer

• Paragon Bioservices Bolsters Leadership Ranks With Executive Appointments, New VP Hires

  1/25/2018

  The Company appoints Philip Wills, PhD, as CCO, John Conner as CMO, and William "Bill" Thomas, Jr., PhD, as CSO, and hires Randy Henrickson as VP of Manufacturing and Dermot McCaul as VP of Information Technology.

• 

  Paragon Bioservices to Create 200 New Jobs in Expansion

  1/23/2018

  The new planned 150,000 square-foot facility, located in Maryland's Anne Arundel County, will facilitate Paragon's continued rapid growth.

• Paragon Bioservices Appoints Deborah Wild As VP Quality and Regulatory Affairs

  7/20/2017

• Paragon Bioservices Release: NIAID Awards Company A Multiple Award IDIQ Contract Valued Up To $159 Million For Preclinical Drug Development Services

  1/18/2017

• Paragon Bioservices Appoints John Conner As SVP GMP Manufacturing

  11/22/2016

• Paragon Bioservices Appoints Ruby Hofmann As VP Of Human Resources And Organizational Development

  11/18/2016

• Paragon Bioservices Announces Promotion Of Peter Buzy To President And CEO And Election To Paragon's Board Of Directors

  9/12/2016

• Paragon Bioservices Hires Mark Adams As VP Of Project Management

  8/10/2016

• CEVEC And Paragon Bioservices Enter Into Comprehensive Collaboration To Roll Out CAP Technologies In North America

  6/6/2016

• Paragon Bioservices Recognized As "Best Contract Manufacturing Organization" By World Vaccine Congress 2016

  4/5/2016

• Paragon Bioservices Hires Bill Thomas As Chief Technology Officer

  3/7/2016

• Paragon Bioservices Wins CMO Leadership Awards

  2/9/2016

• Paragon Bioservices Founder Marco Chacon Appointed By Governor Hogan To Maryland Life Sciences Advisory Board

  2/4/2016

• Paragon Bioservices Founder Dr. Marco Chacon Elevated To Chairman

  2/3/2016

• Paragon Bioservices Selected By IAVI For Manufacture Of HIV Vaccine Candidate

  12/1/2015

• Paragon Bioservices Announces The Appointment Of Robert Roche To Its Board Of Directors

  11/12/2015

• Paragon Bioservices Hires Kevin Sly As SVP Marketing & Commercial Strategy

  10/29/2015